ArticleBritish journal of pharmacology2011

The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells.

Ce Tiffon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.